Hyponatremia Management

Introduction to Hyponatremia

Hyponatremia can occur in approximately 0.5% to 12% of older adults taking SSRIs, such as citalopram, with a significantly higher risk compared to other drug classes (OR = 3.3; 95% CI, 1.3 to 8.6), as reported by the American Academy of Family Physicians 1
Underlying diseases such as heart failure, liver cirrhosis, and renal dysfunction increase the risk of hyponatremia, as noted by the European Heart Journal 2
Hypokalemia is also a risk factor for hyponatremia 3

Thiazide diuretics, such as Hydrochlorothiazide, metolazone, and indapamide, are associated with the highest risk of hyponatremia among diuretics, according to the European Society of Cardiology 4
Loop diuretics, including Furosemide, bumetanide, and torasemide, have a lower risk of hyponatremia compared to thiazides, as reported by the European Society of Cardiology 4
Potassium-sparing diuretics, such as Spironolactone, triamterene, and amiloride, are also associated with hyponatremia, as noted by the European Society of Cardiology 4

Thiazide diuretics and selective serotonin reuptake inhibitors (SSRIs) are the most common medications implicated in drug-induced hyponatremia, especially in elderly patients and those with baseline sodium levels at the lower limit of normal, as stated by the European Society of Cardiology 3
Loop diuretics have a lower risk of causing hyponatremia than thiazides, but still pose a significant risk, especially when combined with other medications, as noted by the American College of Cardiology and the European Society of Cardiology 5, 3
Vasopressin analogues, such as terlipressin, are noted to cause hyponatremia as a side effect, according to the Clinical and Molecular Hepatology guidelines 6
Vasopressin antagonists, such as conivaptan and tolvaptan, can paradoxically cause hyponatremia in certain contexts, according to Clinical and Molecular Hepatology and the American Association for the Study of Liver Diseases 7, 8

Elderly patients, particularly those over 65 years, are at a higher risk of developing hyponatremia while taking citalopram 1
Female patients and those with low body weight are also at an increased risk of hyponatremia while taking citalopram 1

Patients with citalopram-induced hyponatremia may present with headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness, which may lead to falls, and in severe cases, hallucinations, syncope, seizures, coma, and respiratory arrest 1

The American Academy of Family Physicians recommends monitoring sodium levels in high-risk patients, checking baseline sodium before starting citalopram, and rechecking within 2-4 weeks of initiation, particularly in elderly patients 1
High-risk patients should have serum sodium checked within 2-4 weeks of starting at-risk medications, as recommended by the American College of Physicians, and require closer monitoring if on combination therapy 9
Identifying risk factors before prescribing medications that can cause hyponatremia, monitoring electrolytes in high-risk patients, and educating patients on symptoms of hyponatremia and when to seek medical attention are recommended by the European Heart Journal 2

For mild asymptomatic hyponatremia, fluid restriction (1-1.5 L/day) may be considered if sodium levels are <125 mmol/L, as suggested by the Clinical and Molecular Hepatology society 7
For mild hyponatremia, monitoring and fluid restriction to 1,000 mL/day may be sufficient, though fluid restriction is not necessary in treating most patients with mild asymptomatic hyponatremia, as suggested by the American Association for the Study of Liver Diseases 10, 11
For moderate to severe hyponatremia, discontinuation of the offending medication, severe fluid restriction, and albumin infusion may be necessary, with a correction rate not exceeding 8 mmol/L per day to prevent central pontine myelinolysis, as recommended by the European Society of Cardiology and the European Association for the Study of the Liver 3, 12
Heart failure patients with serum sodium <135 mmol/L should be referred to specialist care, according to the European Society of Cardiology 4

Patient education about symptoms of hyponatremia and when to seek medical attention is crucial, as emphasized by the European Society of Cardiology 3
Patients with a history of hyponatremia should be considered for alternative medications with a lower risk of causing hyponatremia, as stated by the American Association for the Study of Liver Diseases 8